Contacts: John J. Viscogliosi, CEO, Raymedica, Inc. (952) 885-0500


Minneapolis, MN: May 2, 2005 - Raymedica Inc., a medical device developer and manufacturer, announced that Fred Kornahrens joins Raymedica in the newly created position of Chief Operating Officer.

“Raymedica has currently refocused by continuing to improve on the existing PDN® technology, the world’s first nucleus replacement device, while also creating a comprehensive nucleus replacement system”, said John J. Viscogliosi, Chairmen and CEO of Raymedica. “Fred is a seasoned leader that brings over sixteen years of solid medical device experience to Raymedica including start-up ventures, with over ten of these years consisting of executive management in medical devices.” Fred most recently served as a member of the Executive Staff at Zimmer Spine as Vice President, Global Product Development where he played a vital role in the development, approval and market introduction of several spine products. Fred generated & managed multimillion-dollar budgets leading a global organization of over 40 Product Development, Clinical and Regulatory personnel. Fred also provided key leadership for the global integration of Zimmer Spine Product Development. Prior to joining Zimmer Spine, he served as the Vice President, R&D/Clinical at IntraTherapeutics, Inc., a cardiovascular start-up that was acquired by Sulzer Medica. Under Fred’s leadership, the company launched several Class II & Class III products. He was also instrumental in the sale of ITI during Sulzer Medica’s divestiture of its cardiovascular business units in 2002.

“I am honored to be part of the new Raymedica”, said Fred Kornahrens. “I understand and appreciate the expanding market need for a nucleus replacement device and Raymedica is the true pioneer of nucleus replacement with over 3400 implants. The new Raymedica team has a clear vision to change the paradigm of spine surgery worldwide by delivering superior patient outcomes, resulting in owning the mindshare of spine surgeons & maximizing shareholder value”

John Viscogliosi continued by saying, “Prior to his accomplished medical device career, Fred served for seven years in the Air Force as a B-52 Pilot and Commander. Fred completed his MBA at Renssselaer Polytechnic Institute and received his Bachelor of Science, Engineering from the United States Air Force Academy. He is also a named co-inventor on several patents.”

About Raymedica, Inc.
Raymedica develops, manufactures and markets medical device systems designed to treat patients with degenerative disc disease that have not responded to non-surgical treatment. Raymedica pioneered and is the scientific, clinical and regulatory leader in the nucleus replacement segment of the non-fusion spine market. Raymedica devices have been used in more than 3,400 procedures globally. Raymedica’s products are currently available worldwide, but are limited to investigational use only in the United States.

For more information, visit the Company's website at:

> Back to Press Releases


Viscogliosi Bros., LLC is not an investment adviser, money manager, asset manager or otherwise give investment advice.